Semler Scientific, Inc. (NASDAQ:SMLR) Shares Bought by Cerity Partners LLC

Cerity Partners LLC raised its position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 91.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,345,586 shares of the company's stock after acquiring an additional 642,982 shares during the period. Cerity Partners LLC owned approximately 18.52% of Semler Scientific worth $31,689,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. CWM LLC increased its stake in Semler Scientific by 486.3% in the second quarter. CWM LLC now owns 897 shares of the company's stock worth $31,000 after purchasing an additional 744 shares during the period. Newbridge Financial Services Group Inc. purchased a new position in Semler Scientific in the 2nd quarter worth about $34,000. Quest Partners LLC purchased a new position in Semler Scientific in the 2nd quarter worth about $59,000. Meeder Asset Management Inc. bought a new stake in shares of Semler Scientific during the second quarter valued at approximately $67,000. Finally, US Bancorp DE increased its position in Semler Scientific by 60.8% during the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company's stock valued at $72,000 after purchasing an additional 1,158 shares during the period. Hedge funds and other institutional investors own 49.37% of the company's stock.

Insiders Place Their Bets

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm's stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the transaction, the chief executive officer now owns 60,220 shares of the company's stock, valued at approximately $1,707,237. This trade represents a 14.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 30.20% of the company's stock.

Semler Scientific Price Performance

NASDAQ SMLR traded down $2.42 during midday trading on Monday, hitting $61.23. 1,754,456 shares of the company traded hands, compared to its average volume of 248,784. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $79.45. The company has a market cap of $445.14 million, a PE ratio of 29.87 and a beta of 0.92. The company's 50-day simple moving average is $32.45 and its 200-day simple moving average is $30.85.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The company had revenue of $13.51 million during the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.